News Tivicay approved in Europe in new dispersible tablet for chi... ViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living with HIV.
News Novo partners with Hims & Hers again, ending GLP-1 spat Novo Nordisk and Hims & Hers have set their differences aside, agreeing to work together once again on the sale of GLP-1 agonists.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
